LATHAM, N.Y. (AP) — LATHAM, N.Y. (AP) — AngioDynamics Inc. (ANGO) on Wednesday reported a loss of $10.7 million in its fiscal second quarter.
On a per-share basis, the Latham, New York-based company said it had a loss of 26 cents. Losses, adjusted for costs related to mergers and acquisitions and amortization costs, were 4 cents per share.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 11 cents per share.
The medical device maker posted revenue of $72.8 million in the period, also surpassing Street forecasts. Three analysts surveyed by Zacks expected $71.2 million.
AngioDynamics expects full-year earnings in the range of 34 cents to 38 cents per share, with revenue in the range of $282 million to $288 million.
AngioDynamics shares have risen roughly 3% since the beginning of the year. The stock has increased 47% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ANGO at https://www.zacks.com/ap/ANGO
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
